Correlation Between Pasithea Therapeutics and Adagene
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Adagene, you can compare the effects of market volatilities on Pasithea Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Adagene.
Diversification Opportunities for Pasithea Therapeutics and Adagene
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pasithea and Adagene is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Adagene go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Adagene
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 8.57 times more return on investment than Adagene. However, Pasithea Therapeutics is 8.57 times more volatile than Adagene. It trades about 0.16 of its potential returns per unit of risk. Adagene is currently generating about -0.11 per unit of risk. If you would invest 2.19 in Pasithea Therapeutics Corp on October 20, 2024 and sell it today you would earn a total of 0.32 from holding Pasithea Therapeutics Corp or generate 14.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 50.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Adagene
Performance |
| Timeline |
| Pasithea Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Adagene |
Pasithea Therapeutics and Adagene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Adagene
The main advantage of trading using opposite Pasithea Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.The idea behind Pasithea Therapeutics Corp and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |